Key result
Periostin mediates tissue degeneration in spinal components through mechanical and inflammatory stress pathways, highlighting its potential as a biomarker and therapeutic target for spinal degenerative diseases.
Why the study?
The cause of spinal degenerative diseases remains unclear, and studies on the pathophysiological effects of periostin may significantly contribute toward their diagnosis and treatment.
This review highlights the role of periostin in the pathogenesis of spinal degenerative diseases and its potential utility as a biomarker for diagnosis and disease severity.
Hypothesis-generating for periostin in spinal degeneration; leaves open prospective validation as biomarker or target.
Periostin (POSTN) serves a dual role as both a matricellular protein and an extracellular matrix (ECM) protein and is widely expressed in various tissues and cells. As an ECM protein, POSTN binds to integrin receptors, transduces signals to cells, enabling cell activation. POSTN has been linked with various diseases, including atopic dermatitis, asthma, and the progression of multiple cancers. Recently, its association with orthopedic diseases, such as osteoporosis, osteoarthritis resulting from cartilage destruction, degenerative diseases of the intervertebral disks, and ligament degenerative diseases, has also become apparent. Furthermore, POSTN has been shown to be a valuable biomarker for understanding the pathophysiology of orthopedic diseases. In addition to serum POSTN, synovial fluid POSTN in joints has been reported to be useful as a biomarker. Risk factors for spinal degenerative diseases include aging, mechanical stress, trauma, genetic predisposition, obesity, and metabolic syndrome, but the cause of spinal degenerative diseases (SDDs) remains unclear. Studies on the pathophysiological effects of POSTN may significantly contribute toward the diagnosis and treatment of spinal degenerative diseases. Therefore, in this review, we aim to examine the mechanisms of tissue degeneration caused by mechanical and inflammatory stresses in the bones, cartilage, intervertebral disks, and ligaments, which are crucial components of the spine, with a focus on POSTN.
No takes yet. Share an insight, caveat, or question.
Yoshihara et al. (2023) conducted a review in Spinal degenerative diseases. Periostin (POSTN) was evaluated. Periostin mediates tissue degeneration in spinal components through mechanical and inflammatory stress pathways, highlighting its potential as a biomarker and therapeutic target for spinal degenerative diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: